ArticleJournal of gastrointestinal oncology2014

Durable response with a combination of imatinib and sorafenib in KIT exon 17 mutant gastrointestinal stromal tumor.

Brian Singeltary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.